- SINOVAC Biotech Ltd. (SVA, Financial) accelerates payment of previously announced special dividend of US$55.00 per common share.
- The company declares a second special cash dividend of US$19.00 per common share, with potential for further distributions.
- A new dividend policy is adopted, aiming to return cash between US$20.00–US$50.00 per share to shareholders regularly.
The Board of Directors of SINOVAC Biotech Ltd. (SVA) has announced the acceleration of a previously declared special cash dividend of US$55.00 per common share. This payment is expected to be made around July 7, 2025, ahead of the Special Shareholder Meeting scheduled for July 8. This move comes amidst ongoing lawsuits and claims from a dissenting investor group vying to remove the current SINOVAC Board.
In addition to accelerating the existing dividend payment, SINOVAC has declared a second special cash dividend of US$19.00 per common share. Should legal proceedings regarding PIPE shares conclude with a cancellation, shareholders could receive an additional US$3.73 per share. This effort is part of SINOVAC's commitment to equity for all shareholders, particularly after distributions were previously skewed towards minority shareholders during past board governance.
Furthermore, SINOVAC has adopted a new dividend policy to ensure regular returns from surplus cash to shareholders, estimated to be between US$20.00–US$50.00 per common share in the future. This policy aims to remedy past imbalances in dividend distribution and align with the company's long-term strategic goals.
The company is also exploring listing venues such as The Stock Exchange of Hong Kong to enhance liquidity and reduce geopolitical risks, indicating a proactive approach towards maximizing shareholder value. An annual meeting of shareholders is planned for Q2 2026, with new director nominees anticipated to strengthen corporate governance and strategy alignment.
Also check out: (Free Trial)
